GSK, Innoviva seek EMA approval for Trelegy Ellipta to treat asthma in adults

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Feb 28, 2020 at 10:42 AM.

  1. #1 cafead, Feb 28, 2020 at 10:42 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,028
    Likes Received:
    3
    via British drugmaker GlaxoSmithKline (GSK) and Innoviva are seeking approval from the European Medicines Agency (EMA) for an additional indication of Trelegy Ellipta to treat adult patients with asthma.

    article source
     
    Quote

Reply to Thread